Celestica initiated with an Overweight at Barclays - Nasdaq

Celestica Initiated With An Overweight At Barclays - Nasdaq

2 weeks from now

Nov 5, 2024  · Barclays analyst George Wang initiated coverage of Celestica (CLS) with an Overweight rating and $91 price target As a North American tier 1 electronics manufacturing services and original design ...

nasdaq.com

Celestica (NYSE:CLS) Trading Up 4.8% Following Analyst Upgrade

2 weeks from now

Jan 8, 2025  · Barclays initiated coverage on shares of Celestica in a report on Tuesday, November 5th. They issued an "overweight" rating and a $91.00 target price on the stock. …

marketbeat.com

Celestica (NYSE:CLS) Reaches New 12-Month High - ETF Daily News

2 weeks from now

Jan 6, 2025  · Barclays initiated coverage on shares of Celestica in a research note on Tuesday, November 5th. They set an “overweight” rating and a $91.00 price objective on the stock.

etfdailynews.com

Celestica Initiated With An Overweight At Barclays

2 weeks from now

Nov 5, 2024  · Barclays analyst George Wang initiated coverage of Celestica with an Overweight rating and $91 price target As a North American tier 1 electronics manufacturing services and …

businessinsider.com

Barclays Starts Celestica Coverage With 'overweight' Rating

2 weeks from now

Nov 5, 2024  · ** Electronics manufacturing services company Celestica's CLS shares up 4.8% to $75.82 ** Barclays initiates CLS coverage with "overweight" rating ** Brokerage says the …

tradingview.com

Celestica Shares Are Trading Higher After Barclays Initiated Coverage ...

2 weeks from now

Nov 5, 2024  · Celestica shares are trading higher after Barclays initiated coverage on the stock with an Overweight rating and announced a price target of $91.

sahmcapital.com

Celestica (CLS) Receives A Buy From Barclays - Markets Insider

2 weeks from now

Nov 5, 2024  · Barclays analyst George Wang CFA initiated coverage with a Buy rating on Celestica (CLS – Research Report) today and set a price target of $91.00. The company’s …

businessinsider.com

Celestica Raises FY24 EPS View To $3.85 From $3.62, Consensus $3.65

2 weeks from now

Oct 24, 2024  · Celestica initiated with an Overweight at Barclays. TipRanks 21d. Celestica (CLS) Receives a Buy from Barclays. TipRanks 21d. ... Nasdaq 100; Nasdaq Composite;

businessinsider.com

Celestica Call Volume Above Normal And Directionally Bullish

2 weeks from now

Nov 19, 2024  · Bullish option flow detected in Celestica (CLS) with 9,734 calls trading, 1.4x expected, and implied vol increasing over 1 point to 51.34%. 11/29 weekly 89 calls and Dec …

nasdaq.com

Barclays Initiates Coverage Of VICI Properties (VICI) With ... - Nasdaq

2 weeks from now

Dec 23, 2024  · Fintel reports that on January 10, 2025, Barclays initiated coverage of VICI Properties with a Overweight recommendation.. Analyst Price Forecast Suggests 29.26% …

nasdaq.com

CRH Initiated With An Overweight At Barclays | Nasdaq

2 weeks from now

Oct 29, 2024  · Barclays initiated coverage of CRH (CRH) with an Overweight rating and $110 price target The company relisted a year ago in the U.S. and yet only a few U.S.-based …

nasdaq.com

Orchestra BioMed Initiated With An Overweight At Barclays - Nasdaq

2 weeks from now

Jan 2, 2025  · Barclays initiated coverage of Orchestra BioMed (OBIO) with an Overweight rating and $16 price target The firm sees a "series of catalysts" over the next 12-18 months for …

nasdaq.com

Levi Strauss Initiated With An Overweight At Barclays | Nasdaq

2 weeks from now

Jan 8, 2025  · Barclays initiated coverage of Levi Strauss (LEVI) with an Overweight rating and $24 price target The analyst believes the company’s organic sales in 2025 should accelerate …

nasdaq.com